NCPA CEO B. Douglas Hoey, RPh, MBA, discusses the problems and opportunities facing independent pharmacies.
What you need to know about the upcoming NCPA convention.
Pharmacists are uniquely poised to combat the opioid crisis. Here's what pharmacists (and Congress) can do about it.
Proponents argue that limits reduce the risk of addiction, but are they keeping pharmacists from caring for their patients?
A study commissioned by the NCPA shows the effect of DIR fees.
How one day could help your patients manage their meds.
PBMs are evolving, but what will they be evolving into and will they be more transparent?
The use of health IT has exploded in the last decade, and that means better health care.
How pharmacists are helping to push vital health efforts.
Legislators say it will help ease the problem, but the NCPA says it’s just one part of the solution.